Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1974 Oct;71(10):4052-6.
doi: 10.1073/pnas.71.10.4052.

Antiinflammatory effects of murine malignant cells

Antiinflammatory effects of murine malignant cells

R M Fauve et al. Proc Natl Acad Sci U S A. 1974 Oct.

Abstract

Development of teratocarcinoma does not impair immunization of mice against Listeria monocytogenes. Endotoxin injection a short time before tumor cell inoculation allows the growth of teratocarcinoma in non syngenic mice despite immune stimulation. In contrast with this absence of impaired systematic immunity, teratocarcinoma cells were found to repulse macrophages in vitro. This effect on macrophages was also found with three other malignant cells and with trophoblast cells. In vivo, teratocarcinoma cells were found to impair local inflammation. These cells and other malignant cells are able to produce a compound(s) of molecular weight between 10(3) and 10(4), which prevents inflammatory reaction. These results suggest that mouse teratocarcinomas and other tumors by-pass the host immunological system of surveillance by at least two mechanisms: a direct toxic effect on macrophages and the release of an inhibitor of inflammation. The possible relations between these properties of malignant cells and physiological functions of trophoblast are discussed.

PubMed Disclaimer

References

    1. J Natl Cancer Inst. 1958 Jun;20(6):1257-75 - PubMed
    1. Prog Exp Tumor Res. 1966;8:1-25 - PubMed
    1. Proc Natl Acad Sci U S A. 1973 Oct;70(10):2988-92 - PubMed
    1. Ann Microbiol (Paris). 1973 Oct;124(3):269-82 - PubMed
    1. Adv Immunol. 1971;14:1-84 - PubMed

LinkOut - more resources